Effectiveness and Safety of Percutaneous Adhesiolysis Using Rac'z Catheter Versus Navi Catheter in Management of Failed Back Surgery Syndrome
1 other identifier
interventional
60
1 country
1
Brief Summary
In the past decade, spine surgery rates have dramatically increased in parallel to those of other procedural interventions. Persistent pain is a common occurrence after spine surgery, with the most commonly quoted prevalence rates ranging from 10% to 40%. This pain can be classified into failure to alleviate baseline pain, pain resulting from complications (e.g., arachnoiditis and epidural adhesions), and pain that ensues several years later as a sequele to alterations in spinal architecture and biomechanics (e.g., adjacent segment discogenic or facetogenic pain) which is called failed back surgery syndrome ( FBSS )
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2021
CompletedFirst Posted
Study publicly available on registry
August 24, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 13, 2023
CompletedFebruary 5, 2025
February 1, 2025
1 year
March 15, 2021
February 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
numerical rating scale
The VAS score was used that has 0-10 points. The 0 point represents the painless state and a score from 1 to 3 points represents mild pain, from 4 to 6 points represents moderate pain and from 7 to 10 points represents severe pain.
12 months
Secondary Outcomes (2)
Oswestry Disability Index (ODI)
12 month
pregabalin consumption
12 month
Study Arms (2)
Raj'z catheter
ACTIVE COMPARATORNAVI catheter
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Patients with history of lumbar surgery of at least 6 months duration in the past.
- Patients over the 18 years of age.
- History of persistent function-limiting lower extremity pain aggravated by "dural tug" (observed when the patient, sitting on the exam table with legs stretched out, bends forward, bringing on the back pain) with or without low back pain of at least 6 months duration after failure of conventional conservative management in most patients including NSAIDS, muscle relaxants (tizanidine, magnesium sulphate) and pregabalin.
- Patients who are competent to understand the study protocol and provide voluntary, written informed consent and participate in outcome measurements.
You may not qualify if:
- Unstable or heavy opioid use.
- Uncontrolled psychiatric disorders.
- Uncontrolled medical illness.
- Any conditions that could interfere with the interpretation of the outcome assessments.
- Pregnant or lactating women.
- Patients with a history or potential for adverse reaction(s) to local anaesthetics or steroid.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saeid Metwaly Elsawy
Asyut, 71111, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of anesthesia
Study Record Dates
First Submitted
March 15, 2021
First Posted
August 24, 2021
Study Start
September 1, 2021
Primary Completion
September 1, 2022
Study Completion
August 13, 2023
Last Updated
February 5, 2025
Record last verified: 2025-02